https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=57

Biomedical Research Centre news

Reduced risk of pulmonary embolism in children treated with long term parenteral nutrition

28 Jun 2016, 2:08 p.m.

Researchers at Great Ormond Street Hospital (GOSH) have shown a reduction in the incidence of pulmonary embolism in patients receiving parenteral nutrition after the introduction of a new mixed intravenous lipid emulsion.

Biomarin release results from CLN2 trial being carried out at GOSH

28 Jun 2016, 2:05 p.m.

Biomarin have released positive 48-week results from a clinical trial of cerliponase alfa treatment for CLN2 disease.

Dr Wendy Heywood awarded investigator initiated research proposal from Shire Pharmaceuticals

28 Jun 2016, 2:01 p.m.

Following NIHR Great Ormond Street BRC support, which led to the creation of a high-throughput targeted proteomic urine test, Dr Wendy Heywood has been awarded an industry investigator initiated award from Shire Pharmaceuticals.

Positive preliminary results from the Rapid Paediatric Sequencing Project

28 Jun 2016, 1:56 p.m.

The Rapid Paediatric Sequencing Project (RaPs) is a pilot project aimed at evaluating the use of rapid whole genome sequencing (WGS) for rare diseases in a clinical setting. Successful results have been received from the first patients to have taken part.

UCLB and F-Prime launch Orchard Therapeutics to treat rare childhood diseases

3 May 2016, 3:33 p.m.

Orchard Therapeutics launches with £21-million Series A funding round